Heterogeneous graph neural networks with biological prior knowledge for interpretable drug repurposing in triple-negative breast cancer
Drug repurposing offers a cost-effective path to new therapies for triple-negative breast cancer (TNBC), a subtype with limited targeted treatment options. We present PRECISION, a framework integrating transcription factor (TF) regulatory networks, protein-protein interactions, and drug-target edges into a heterogeneou...